SYNGENEBSESyngene International LtdMediumNeutral
Announced Wed, 20 May · 22:00 IST

Intimation of Postal Ballot and Cut-off date

Board & Shareholder Meetings View source PDF

SYNGENE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹467.50
prior close
₹473.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.4-0.6-1.0-1.1-1.6-0.7-1.5-5.5-5.6-2.4-5.0-11.1
Up moveDown movePending
AI summary

Syngene International is seeking shareholder approval via postal ballot for Ms. Kiran Mazumdar-Shaw to transition from Non-Executive Chairperson to Executive Chairperson (a Key Managerial Personnel) effective April 1, 2026. Under the proposed change, she will receive annual remuneration of Rs. 4 Crores (Rs. 33.33 lakhs monthly) for a 5-year tenure. The company posted revenue of Rs. 34,907 million in FY26 with PAT of Rs. 3,049 million. Kiran Mazumdar-Shaw is a promoter holding 15.68% beneficial ownership. Remote e-voting runs from May 21 to June 19, 2026, with results expected by June 23, 2026. This requires a Special Resolution under SEBI Listing Regulations.

Likely market impact

Shareholders should approve this change as it formalizes the founder's executive involvement, providing stronger leadership continuity. The Rs. 4 Crores remuneration is modest relative to company profits and aligned with industry standards. This is positive for governance given her extensive biotech experience.